Nova Leap Health Corp. Enters Into Term Sheet to Amend Its Credit Agreement for up to an Additional $7 Million to Support Continued Growth
Nova Leap Health Corp. Enters Into Term Sheet to Amend Its Credit Agreement for up to an Additional $7 Million to Support Continued Growth
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
未經美國本土新聞電線服務傳播或分發。
HALIFAX, Nova Scotia, Nov. 26, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has entered into an agreement to amend its existing credit agreement (the "Credit Agreement") with BMO Bank of Montreal for new credit facilities (the "Credit Facilities"). The amended Credit Agreement will provide up to an additional $7 million of available credit to support the Company's long-term growth strategy. All amounts are in United States dollars unless otherwise specified.
新斯科舍省哈利法克斯,2024年11月26日(環球新聞)- NOVA LEAP HEALTH CORP.(TSXV: NLH)(「Nova Leap」或「公司」),一家不斷增長的家庭醫療保健組織,很高興宣佈已與蒙特利爾銀行(BMO Bank of Montreal)就新信貸工具(「信貸工具」)的現有信貸協議(「信貸協議」)進行修訂達成協議。修訂後的信貸協議將提供多達額外700萬美元的可用信貸,以支持公司的長期增長策略。除非另有說明,所有金額均以美元計算。
The Credit Facilities consist of non-readvanceable demand acquisition lines to assist with business acquisitions, including the Nova Scotia acquisition announced on October 29, 2024, the Florida acquisition announced on October 15, 2024, and future business acquisitions approved by the lender, in addition to the Company's existing facilities for working capital and day-to-day operating needs. The acquisition lines are available as CAD prime (prime rate plus 1.50%) and USD base rate (base rate plus 1.50%) loans, as well as fixed rate loans with rates determined at the time of booking.
信貸工具包括不可再借的需求獲取信貸額,用於業務收購,包括已於2024年10月29日宣佈的新斯科舍省收購,於2024年10月15日宣佈的佛羅里達州收購,以及由貸款人批准的未來業務收購,另外還包括公司現有的爲營運資金和日常運營需求提供的信貸額。這些收購額可以作爲加拿大元基準利率(基準利率加1.50%)和美元基準利率(基準利率加1.50%)貸款,以及根據預訂時間確定利率的固定利率貸款。
The Credit Facilities contain financial and other covenants and security in favour of the lender which are customary for facilities of this nature, including security over the assets of the Company and its subsidiaries, and are conditional upon obtaining coverage under Export Development Canada's Export Guarantee Program.
信貸工具包含適用於此類信貸工具的財務和其他契約以及有利於貸款人的擔保,包括對公司及其子公司資產的擔保,並且須獲得加拿大出口發展公司(Export Development Canada)的出口擔保計劃的保險才能生效。
Management Comments
管理層評論
"We are pleased to secure the new Credit Facilities. Our ability to complete this transaction reflects the consistent cash flow and financial results that we have produced. With our strong Adjusted EBITDA over the past six quarters, our capital structure can comfortably support increased debt, while still maintaining financial flexibility," said Chris LeBlanc, Chief Financial Officer of Nova Leap.
我們很高興獲得新的信貸額度。我們成功完成這筆交易的能力反映了我們產生的持續現金流和財務業績。根據過去六個季度的強勁調整後的稅息折舊及攤銷前利潤,我們的資本結構可以輕鬆支持增加債務,同時保持財務靈活性,"nova首席財務官Chris LeBlanc表示。
"The successful negotiation of the Credit Facilities provides us with greater financial flexibility to execute on our growth strategy that consists of investing in our business to drive organic growth and in pursuing strategic acquisitions," said Chris Dobbin, President & CEO of Nova Leap.
成功談判信貸額度爲我們提供了更大的財務靈活性,以執行我們的增長策略,包括投資於業務以推動有機增長並追求戰略收購,"nova首席執行官Chris Dobbin表示。
About Nova Leap
關於Nova Leap
Nova Leap is an acquisitive home health care services company operating in one of the fastest-growing industries in the U.S. & Canada. The Company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care. Nova Leap achieved the #42 ranking on the 2021 Report on Business ranking of Canada's Top Growing Companies, the #2 ranking on the 2020 Report on Business ranking of Canada's Top Growing Companies and the #10 Ranking in the 2019 TSX Venture 50 in the Clean Technology & Life Sciences sector. The Company is geographically diversified with operations in 10 different U.S. states within the New England, Southeastern, South Central and Midwest regions as well as in Nova Scotia, Canada.
Nova Leap是一家收購型家庭醫療保健服務公司,在美國和加拿大增長最快的行業之一進行運營。公司在關注個人和家庭的基礎上扮演着至關重要的角色,特別是那些需要癡呆症護理的人。Nova Leap在加拿大2021年Ranking of Canada's Top Growing Companies排名第42,在2020年Ranking of Canada's Top Growing Companies排名第2,在2019年TSX Venture 50中排名第10,屬於清潔技術和生命科學板塊。該公司業務遍佈新英格蘭、東南部、南部和中西部等10個美國州,以及加拿大新斯科舍。
NON-IFRS MEASURES:
非IFRS衡量標準:
This release contains references to certain measures that do not have a standardized meaning under IFRS as prescribed by the International Accounting Standards Board ("IASB") and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement IFRS measures by providing a further understanding of operations from management's perspective. Accordingly, non-IFRS financial measures should not be considered in isolation or as a substitute for analysis of financial information reported under IFRS. The Company presents non-IFRS financial measures, specifically Adjusted EBITDA (as such term is hereinafter defined), as well as supplementary financial measures such as annualized revenue and annualized adjusted EBITDA. The Company believes these non-IFRS financial measures are frequently used by lenders, securities analysts, investors and other interested parties as a measure of financial performance, and it is therefore helpful to provide supplemental measures of operating performance and thus highlight trends that may not otherwise be apparent when relying solely on IFRS financial measures.
本報告涉及某些措施,這些措施在國際會計準則理事會("IASB")規定的IFRS下沒有標準化的含義,因此可能不適合與其他公司提供的類似措施進行比較。相反,這些措施作爲補充信息提供,以補充IFRS措施,從管理角度提供進一步的運營理解。因此,不應將非IFRS財務措施作爲孤立的分析或替代IFRS下報告的財務信息。公司提供非IFRS財務措施,特別是調整後EBITDA(如下文所定義),以及年化營業收入和年化調整後EBITDA等補充財務措施。公司認爲,這些非IFRS財務措施經常被放貸人、證券分析師、投資者和其他感興趣的各方用作衡量財務業績的指標,因此提供運營績效的補充措施,並突出當僅依靠IFRS財務措施時可能不明顯的趨勢。
Adjusted Earnings before interest, taxes, amortization and depreciation ("Adjusted EBITDA"), is calculated as income from operating activities plus amortization and depreciation and stock-based compensation expense. The most directly comparable IFRS measure is income from operating activities.
經營性收益加上攤銷和折舊以及股票補償費用,即爲調整後的息稅前利潤("調整後的EBITDA")計算方法。最直接可比的IFRS衡量指標爲經營性收益。
FORWARD LOOKING INFORMATION:
前瞻性信息:
Certain information in this press release may contain forward-looking statements, such as statements regarding availability of the Credit Facilities, the closing of the acquisitions (including timing) and its expected impact on the Company, financing of the acquisitions, and plans regarding future acquisitions and business growth. This information is based on current expectations and assumptions, including assumptions described elsewhere in this release and those concerning general economic and market conditions, the satisfaction of conditions to closing the Credit Facilities and the acquisitions, availability of working capital necessary for conducting Nova Leap's operations, availability of desirable acquisition targets and financing to fund such acquisitions, and Nova Leap's ability to integrate its acquired businesses and maintain previously achieved service hour and revenue levels, that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. Risks that could cause results to differ from those stated in the forward-looking statements in this release include staff and supply shortages, regulatory changes affecting the home care industry or government programs utilized by the Company, other unexpected increases in operating costs and competition from other service providers. All forward-looking statements, including any financial outlook or future-oriented financial information, contained in this press release are made as of the date of this release and included for the purpose of providing information about management's current expectations and plans relating to the future, and these statements may not be appropriate for other purposes. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company's filings with the Canadian securities regulators, which filings are available at .
本新聞稿中的某些信息可能包含前瞻性陳述,如有關信貸額度可用性、收購的完成(包括時間安排)以及對公司預期影響、收購的融資、未來收購和業務增長計劃的陳述。這些信息基於目前的期望和假設,包括本新聞稿中描述的假設和關於一般經濟和市場情況、符合信貸額度和收購完成條件、爲Nova Leap運營提供必要的營運資本、提供理想收購目標和融資以資助此類收購的可用性,以及Nova Leap整合已收購業務並保持先前達到的服務小時和營收水平的能力等等假設,這些假設都面臨着難以預測的重大風險和不確定性。實際結果可能與任何前瞻性陳述中暗示的結果有很大不同。可能導致結果與本新聞稿中前瞻性陳述中所述結果不同的風險包括員工和供應短缺、影響公司所利用的家庭護理行業或政府方案的監管變化、其他意外的運營成本增加以及與其他服務提供商的競爭。本新聞稿中包含的所有前瞻性陳述,包括任何財務展望或未來導向的財務信息,均截至本新聞稿日期爲止,並僅用於提供有關管理層當前的期望和未來計劃的信息,這些陳述可能不適用於其他目的。除非要求公司遵守適用於公司的證券法規定,否則公司不承擔更新前瞻性陳述或更新導致實際結果可能與前瞻性陳述中反映的結果不同的原因的義務。包含在加拿大證券監管機構備案文件中的標識風險和不確定性的額外信息,請參閱該等備案文件。 .
CAUTIONARY STATEMENT:
警示聲明:
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
TSX tsx Venture交易所及其監管服務提供商(如TSX Venture交易所的政策中所定義的那樣)不承擔此發佈的充分性或準確性的責任。
CONTACT: For further information:
Chris Dobbin, CPA, ICD.D
Director, President and CEO
Nova Leap Health Corp.
E:cdobbin@novaleaphealth.com
聯繫人: 欲獲得更多信息:
Chris Dobbin,註冊會計師,ICD.D
董事、總裁兼首席執行官
nova醫療保健公司。
E: cdobbin@novaleaphealth.com